Pages that link to "Q19546769"
Jump to navigation
Jump to search
The following pages link to Rainer Storb (Q19546769):
Displaying 50 items.
- Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation (Q24642254) (← links)
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT (Q24685958) (← links)
- Nonmyeloablative allogeneic hematopoietic cell transplantation (Q26748780) (← links)
- Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation (Q28277744) (← links)
- Use of multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma (Q28299569) (← links)
- Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission (Q28305230) (← links)
- Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine (Q28331277) (← links)
- Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers (Q30432005) (← links)
- Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting (Q30486842) (← links)
- Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model (Q30525173) (← links)
- Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial (Q30543777) (← links)
- Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose (Q30558271) (← links)
- Thalidomide for treatment of patients with chronic graft-versus-host disease. (Q31599290) (← links)
- Organization of the canine major histocompatibility complex: current perspectives (Q31905980) (← links)
- Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation (Q32052653) (← links)
- Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers (Q32052665) (← links)
- Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities (Q33335306) (← links)
- Secondary failure of platelet recovery after hematopoietic stem cell transplantation (Q33336839) (← links)
- Hematopoietic responses to stress conditions in young dogs compared with elderly dogs (Q33337976) (← links)
- Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease (Q33340454) (← links)
- Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone (Q33342878) (← links)
- Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization (Q33343661) (← links)
- Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita (Q33346928) (← links)
- Recombinant human macrophage colony‐stimulating factor‐induced thrombocytopenia in dogs (Q33348052) (← links)
- Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma (Q33348936) (← links)
- Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections (Q33380627) (← links)
- Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor. (Q33380630) (← links)
- Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation (Q33388983) (← links)
- Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs (Q33396929) (← links)
- Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation (Q33398529) (← links)
- Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation (Q33419003) (← links)
- EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis (Q33443876) (← links)
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. (Q33445663) (← links)
- Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease (Q33445669) (← links)
- Clinical and Hematologic Effects of Cross Circulation in Baboons (Q33467912) (← links)
- Cyclophosphamide regimens in rhesus monkey with and without marrow infusion (Q33467991) (← links)
- Platelet and fibrinogen kinetics in canine tumors. (Q33485939) (← links)
- Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. (Q33487881) (← links)
- Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer (Q33488270) (← links)
- Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets (Q33489005) (← links)
- Transplantation of allogeneic peripheral blood stem cells (Q33496544) (← links)
- Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor (Q33496942) (← links)
- Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody (Q33499074) (← links)
- Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome (Q33560410) (← links)
- CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease (Q33584223) (← links)
- Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial (Q33653406) (← links)
- Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation (Q33677489) (← links)
- Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation (Q33710708) (← links)
- Mixed chimerism: preclinical studies and clinical applications (Q33721521) (← links)
- Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging (Q33731159) (← links)